tiprankstipranks
Trending News
More News >
Glenmark Life Sciences Limited (IN:GLS)
:GLS
India Market

Glenmark Life Sciences Limited (GLS) Income Statement

Compare
1 Followers

Glenmark Life Sciences Limited Income Statement

Last quarter (Q1 2024), Glenmark Life Sciences Limited's total revenue was ₹5.89B, an increase of 1.76% from the same quarter last year. In Q1, Glenmark Life Sciences Limited's net income was ₹1.11B. See Glenmark Life Sciences Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
₹ 22.83B₹ 21.61B₹ 21.23B₹ 18.85B₹ 15.37B
Gross Profit
₹ 12.43B₹ 11.47B₹ 10.80B₹ 9.80B₹ 8.47B
Operating Expenses
₹ 3.45B₹ 5.47B₹ 5.01B₹ 4.18B₹ 4.03B
Depreciation and Amortization
₹ 534.52M₹ 420.94M₹ 378.77M₹ 333.94M₹ 293.68M
EBITDA
₹ 6.86B₹ 6.71B₹ 6.31B₹ 5.92B₹ 4.84B
Operating Income
₹ 8.98B₹ 6.01B₹ 5.79B₹ 5.62B₹ 4.44B
Other Income/Expenses
₹ -2.67B₹ -2.31B₹ -2.59B₹ -2.84B₹ -2.05B
Pretax Income
₹ 6.31B₹ 6.29B₹ 5.65B₹ 4.71B₹ 4.21B
Net Income
₹ 4.71B₹ 4.67B₹ 4.19B₹ 3.52B₹ 3.13B
Per Share Metrics
Basic EPS
₹ 38.43₹ 38.11₹ 35.63₹ 32.61₹ 29.04
Diluted EPS
₹ 38.38₹ 38.11₹ 35.63₹ 32.61₹ 29.04
Weighted Average Shares Outstanding
122.53M 122.53M 117.53M 107.80M 107.80M
Weighted Average Shares Outstanding (Diluted)
122.69M 122.53M 117.53M 107.80M 107.80M
Currency in INR

Glenmark Life Sciences Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis